H-CYTE, Inc. (HCYT) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Tampa, FL, 미국. 현재 CEO는 Michael W. Yurkowsky.
HCYT 을(를) 보유 IPO 날짜 2014-12-19, 2 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $624.98K.
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
